Shares of Omega Healthcare Investors Inc (NYSE:OHI) have received an average recommendation of “Hold” from the thirteen research firms that are currently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $34.67.
Several brokerages recently issued reports on OHI. Zacks Investment Research raised Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, October 31st. Stifel Nicolaus lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $39.00 target price on the stock. in a research report on Thursday, February 7th. Scotiabank began coverage on Omega Healthcare Investors in a research report on Thursday, February 7th. They issued a “sector perform” rating and a $39.37 target price on the stock. ValuEngine raised Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research report on Tuesday, November 20th. Finally, Bank of America reaffirmed a “hold” rating on shares of Omega Healthcare Investors in a research report on Monday, November 19th.
In related news, insider Michael Ritz sold 2,000 shares of the stock in a transaction that occurred on Monday, November 19th. The stock was sold at an average price of $35.50, for a total transaction of $71,000.00. Following the completion of the sale, the insider now owns 8,076 shares in the company, valued at approximately $286,698. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Steven J. Insoft sold 50,000 shares of the stock in a transaction that occurred on Thursday, January 31st. The shares were sold at an average price of $40.00, for a total value of $2,000,000.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 86,000 shares of company stock worth $3,321,750. 1.65% of the stock is currently owned by insiders.
Shares of Omega Healthcare Investors stock traded down $2.69 during trading on Friday, hitting $36.57. The stock had a trading volume of 176,869 shares, compared to its average volume of 1,657,602. The company has a quick ratio of 4.17, a current ratio of 4.17 and a debt-to-equity ratio of 1.21. The firm has a market cap of $7.88 billion, a price-to-earnings ratio of 11.07, a price-to-earnings-growth ratio of 6.37 and a beta of 0.52. Omega Healthcare Investors has a fifty-two week low of $25.05 and a fifty-two week high of $40.30.
Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Monday, February 11th. The real estate investment trust reported $0.31 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.43). The company had revenue of $219.75 million for the quarter, compared to analysts’ expectations of $223.27 million. Omega Healthcare Investors had a net margin of 31.91% and a return on equity of 7.32%. Analysts anticipate that Omega Healthcare Investors will post 2.99 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 15th. Stockholders of record on Thursday, January 31st will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 7.22%. The ex-dividend date of this dividend is Wednesday, January 30th. Omega Healthcare Investors’s dividend payout ratio is 80.00%.
About Omega Healthcare Investors
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: Beta
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.